Cargando…
Acquired von Willebrand syndrome (AVWS) type 2, characterized by decreased high molecular weight multimers, is common in children with severe pulmonary hypertension (PH)
BACKGROUND AND OBJECTIVES: Emerging evidence suggests that increased degradation of von Willebrand factor and decrease in high molecular weight multimers occurs in patients with pulmonary hypertension (PH). However, the link between acquired von Willebrand Syndrome (AVWS) type 2 and PH remains poorl...
Autores principales: | Wieland, Ivonne, Diekmann, Franziska, Carlens, Julia, Hinze, Laura, Lambeck, Katharina, Jack, Thomas, Hansmann, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701817/ https://www.ncbi.nlm.nih.gov/pubmed/36452355 http://dx.doi.org/10.3389/fped.2022.1012738 |
Ejemplares similares
-
Combination of acquired von Willebrand syndrome (AVWS) and Glanzmann thrombasthenia in monoclonal gammopathy of uncertain significance (MGUS), a case report
por: Mayne, Elizabeth Sarah, et al.
Publicado: (2018) -
Evaluation of a semi‐automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers
por: Bowyer, Annette E., et al.
Publicado: (2018) -
Establishing reference intervals for von Willebrand factor multimers
por: Pikta, Marika, et al.
Publicado: (2022) -
Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution
por: Vangenechten, Inge, et al.
Publicado: (2020) -
Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis
por: Stockschlaeder, Marcus, et al.
Publicado: (2014)